Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors
Keywords: Quinoline-sulfonamides; Isoquinoline-sulfonamides; Long-chain arylpiperazines; 2,3-Dichlorophenylpiperazine; Serotonin; Dopamine; 5-HT2A antagonist; D2 partial agonist; 5-HT7 antagonist; Aripiprazole; Depression; Schizophrenia